Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: The Radiation Therapy Oncology Group Protocol 92-02 (vol 21, pg 3972, 2003)

被引：9
|
作者：
Hanks
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 02期
关键词：
D O I：
10.1200/JCO.2004.12.921
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：386 / 386
页数：1
相关论文
共 21 条
  • [1] Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: The Radiation Therapy Oncology Group Protocol 92-02
    Hanks, GE
    Pajak, TF
    Porter, A
    Grignon, D
    Brereton, H
    Venkatesan, V
    Horwitz, EM
    Lawton, C
    Rosenthal, SA
    Sandler, HM
    Shipley, WU
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (21) : 3972 - 3978
  • [2] Ten-year follow-up of radiation therapy oncology group protocol 92-02: A phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer
    Horwitz, Eric M.
    Bae, Kyounghwa
    Hanks, Gerald E.
    Porter, Arthur
    Grignon, David J.
    Brereton, Harmar D.
    Venkatesan, Varagur
    Lawton, Colleen A.
    Rosenthal, Seth A.
    Sandler, Howard M.
    Shipley, William U.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15) : 2497 - 2504
  • [3] Phase III Radiation Therapy Oncology Group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate
    Pilepich, MV
    Winter, K
    John, MJ
    Mesic, JB
    Sause, W
    Rubin, P
    Lawton, C
    Machtay, M
    Grignon, D
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 50 (05): : 1243 - 1252
  • [4] Bcl-2 and Bax expression predict prostate cancer outcome in men treated with androgen deprivation and radiotherapy on Radiation Therapy Oncology Group protocol 92-02
    Khor, Li Yan
    Moughan, Jennifer
    Al-Saleem, Tahseen
    Hammond, Elizabeth H.
    Venkatesan, Varagur
    Rosenthal, Seth A.
    Ritter, Mark A.
    Sandler, Howard M.
    Hanks, Gerald E.
    Shipley, William U.
    Pollack, Alan
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (12) : 3585 - 3590
  • [5] Long-term androgen deprivation, with or without radiotherapy, in locally advanced prostate cancer: updated results from a phase III randomised trial
    Sargos, Paul
    Mottet, Nicolas
    Bellera, Carine
    Richaud, Pierre
    [J]. BJU INTERNATIONAL, 2020, 125 (06) : 810 - 816
  • [6] Ki-67 staining is a strong predictor of distant metastasis and mortality for men with prostate cancer treated with radiotherapy plus androgen deprivation: Radiation Therapy Oncology Group trial 92-02
    Pollack, A
    DeSilvio, M
    Khor, LY
    Li, R
    Al-Saleem, TI
    Hammond, ME
    Venkatesan, V
    Lawton, CA
    Roach, M
    Shipley, WU
    Hanks, GE
    Sandler, HM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) : 2133 - 2140
  • [7] PHASE-II RADIATION-THERAPY ONCOLOGY GROUP-STUDY OF HORMONAL CYTOREDUCTION WITH FLUTAMIDE AND ZOLADEX IN LOCALLY ADVANCED-CARCINOMA OF THE PROSTATE TREATED WITH DEFINITIVE RADIOTHERAPY
    PILEPICH, MV
    JOHN, MJ
    KRALL, JM
    MCGOWAN, D
    HWANG, YS
    PEREZ, CA
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (06): : 461 - 464
  • [8] Long-term androgen deprivation, with or without radiotherapy, in locally-advanced prostate cancer: Updated results from a phase III randomized trial.
    Sargos, Paul
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] Long-term treatment sequelae after external beam irradiation with or without hormonal manipulation for adenocarcinoma of the prostate: Analysis of radiation therapy oncology group studies 85-31, 86-10, and 92-02
    Lawton, Colleen A.
    Bae, Kyoungwha
    Pilepich, Miljenko
    Hanks, Gerald
    Shipley, William
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 70 (02): : 437 - 441
  • [10] Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation therapy oncology group 9413
    Roach, M
    DeSilvio, M
    Lawton, C
    Uhl, V
    Machtay, M
    Seider, MJ
    Rotman, M
    Jones, C
    Asbell, SO
    Valicenti, RK
    Han, S
    Thomas, CR
    Shipley, WS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (10) : 1904 - 1911
123